EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Latent, Lytic, and Linked to Multiple Sclerosis—How EBV Drives Autoimmunity

Fabienne Läderach, Elena Bremer iD, Christian Münz

European Journal of Immunology · 2026-02 · 56 (2)

DOI: 10.1002/eji.70153 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Immunology, online erschienen am 22.02.2026. Verfasst von Fabienne Läderach und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland. Hauptthemen laut MEDLINE: Multiple Sclerosis, Herpesvirus 4, Human, Epstein-Barr Virus Infections, Autoimmunity. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Cancer Research Switzerland, UZH Foundation for Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein–Barr virus (EBV) is a human tumor virus best known for its B cell‐transforming capacity and association with lymphomas and carcinomas. Epidemiological studies have suggested that its infection, in addition, is necessary for the development of the autoimmune disease multiple sclerosis (MS). The very same oncogenes that drive EBV‐associated malignancies might also induce differentiation of B cell subsets that initiate neuroinflammation. This review will discuss how insufficient immune control might allow for sizeable populations of T‐bet + CXCR3 + B cells to infiltrate the central nervous system (CNS), attract other lymphocytes, efficiently stimulate T cells in the CNS, and differentiate into antibody‐producing plasma cells, thereby contributing to inflammation and autoantibody production in a subset of MS patients. This CNS‐infiltrating B‐cell population could be targeted by EBV‐specific treatments to complement existing MS therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisHerpesvirus 4, HumanEpstein-Barr Virus InfectionsAutoimmunityHumansAnimalsB-LymphocytesVirus LatencyCentral Nervous System

Stichwörter der Autor:innen

AutoimmunityB cellsCNSEpstein‐Barr virusMultiple‐Sclerosis

Autor:innen und Institutionen

  • Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland.
  • Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Switzerland.

ORCID-Profile: Elena Bremer

Förderung

  • Swiss National Science Foundation
  • Cancer Research Switzerland
  • UZH Foundation for Scientific Research
  • Swiss State Secretariat for Education, Research and Innovation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Läderach, F., Bremer, E., & Münz, C. (2026). Latent, Lytic, and Linked to Multiple Sclerosis—How EBV Drives Autoimmunity. European Journal of Immunology, 56(2). https://doi.org/10.1002/eji.70153

Vancouver

Läderach F, Bremer E, Münz C. Latent, Lytic, and Linked to Multiple Sclerosis—How EBV Drives Autoimmunity. European Journal of Immunology. 2026;56(2). doi:10.1002/eji.70153

BibTeX
@article{Lderach2026,
  author = {Läderach, Fabienne and Bremer, Elena and Münz, Christian},
  title = {Latent, Lytic, and Linked to Multiple Sclerosis—How EBV Drives Autoimmunity},
  journal = {European Journal of Immunology},
  year = {2026},
  volume = {56},
  number = {2},
  doi = {10.1002/eji.70153}
}
Kostenlos starten →